Apoptosis of vascular smooth muscle cells is induced by Fas ligand derived from monocytes/macrophage

Atherosclerosis

Volumn 161, Issue 1, 2002, Pages 143-151

  Imanishi, Toshio ^a,b   Han, David K M ^b   Hofstra, Leonard ^c   Hano, Takuzo ^a   Nishio, Ichiro ^a   Conrad Liles, W ^b   Gorden, Alan M ^d   Schwartz, Stephen M ^b  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF WASHINGTON   (United States)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d PHENOPATH LABORATORIES   (United States)

Author keywords

Apoptosis; Atherosclerosis; Cytokines; Macrophage; Soluble FasL

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE INHIBITOR; FAS ANTIBODY; FAS LIGAND; IMMUNOGLOBULIN G1;

ADULT; ADVENTITIA; AGED; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL ACTIVATION; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CULTURE MEDIUM; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; MACROPHAGE; MALE; MONOCYTE; NICK END LABELING; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; STAINING; VASCULAR SMOOTH MUSCLE;

ANTIGEN-ANTIBODY COMPLEX; APOPTOSIS; ARTERIOSCLEROSIS; BLOTTING, WESTERN; CELLS, CULTURED; CHROMIUM; FAS LIGAND PROTEIN; HUMANS; IN SITU NICK-END LABELING; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MONOCYTES; MUSCLE, SMOOTH, VASCULAR; ZYMOSAN;

EID: 0036188412     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00631-1     Document Type: Article

References (38)

1. Characterization of the relative thrombogenicity of atherosclerotic plaque components: Implications of consequences of plaque rupture
2. Cytokines regulate genes involved in atherogenesis
3. Microscopic localization of active proteases by in situ zymography: Detection of matrix metalloprotease activity in vascular tissue
4. Cell proliferation and collagen synthesis are two independent events in human atherosclerotic plaques
5. Cell proliferation in human coronary arteries
6. Proliferation in primary and restenotic coronary atherectomy tissue: Implications for antiproliferative therapy
7. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques
8. Evidence for apoptosis in advanced human atheroma: Colocalization with interleukin-1β converting enzyme
9. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model
10. Apoptosis in human atherosclerosis and restenosis
11. Apoptosis mediated by the Fas system
12. The Fas death factor
13. Oxidized LDL activates Fas-mediated endothelial cell apoptosis
14. Possible participation of Fas-mediated apoptosis in the mechanism of atherosclerosis
15. The role of Fas/APO1 and apoptosis in the development of human atherosclerotic lesions
16. Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells
17. Human transplant coronary artery disease: Pathological evidence for Fas-mediated apoptotic cytotoxicity in allograft arteriopathy
18. Human monocytic cells contain high levels of intracellular Fas ligand: Rapid release following cellular activation
19. Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages
20. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: Implications for the regulation of apoptosis in neutrophils
21. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity
22. Technical note: Aberrant detection of cell surface Fas ligand with anti-peptide antibodies
23. Expression of cellular FLICE-inhibitory protein in human coronary arteries and in a rat vascular injury model
24. Technical comments: Constitutive expression of FasL in thymocytes
25. Expression of Fas ligand by human cytotrophoblasts: Implications in placentation and fetal survival
26. Fas and Fas ligand in embryos and adult mice: Ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover
27. Oxysterols induced apoptosis in cultured smooth muscle cells through CPP32 protease activation and bcl-2 protein down-regulation
28. The pathogenesis of atherosclerosis: A perspective for the 1990s
29. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways
30. Autocrine T-cell suicide mediated by APO-1/Fas (CD95)
31. Metalloproteinase-mediated released of human Fas ligand
32. Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases
33. Downregulation of Fas ligand by shedding
34. Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with down-regulation of its proapoptotic activity and loss of liver toxicity
35. Phagocytosis triggers macrophage release of Fas ligand and induces apoptosis of bystander leukocytes
36. Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS)
37. Human transplant coronary artery disease: Pathological evidence for Fas-mediated apoptotic cytotoxicity in allograft arteriopathy
38. Accellated atherosclerosis in mice lacking tumor necrosis receptor p55